SciSparc Celebrates Major Breakthrough: Positive Results Show its Treatment has a Remarkable Impact on Alzheimer's Agitation
15 nov. 2023 08h01 HE
|
SciSparc Ltd
Phase IIa trial outcome indicates the potential for a new way to help Alzheimer’s patients’ agitation Tel-Aviv, Nov. 15, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a specialty,...
UPDATE: NXP and Zendar Inc. Accelerate the Development of High-Resolution Radar
02 nov. 2023 05h53 HE
|
NXP USA, Inc.
NXP invests in Zendar Inc. to advance high-resolution and high-performance radar systems for autonomous driving and advanced driver assistance systems (ADAS)Zendar’s Distributed Aperture Radar (DAR)...
NXP and Zendar Inc. Accelerate the Development of High-Resolution Radar
02 nov. 2023 04h00 HE
|
NXP USA, Inc.
NXP invests in Zendar Inc. to advance high-resolution and high-performance radar systems for autonomous driving and advanced driver assistance systems (ADAS)Zendar’s Distributed Aperture Radar (DAR)...
NFI subsidiary Alexander Dennis unveils next-generation electric buses offering more choice, more flexibility, and more value
01 nov. 2023 07h30 HE
|
NFI Group Inc
Nov 1, 2023: NFI subsidiary Alexander Dennis launched its next generation of battery-electric buses for the UK and Ireland
Team One Announces Fifth Annual Legacy Lab Foundation Scholarship Call for Submissions
18 sept. 2023 09h05 HE
|
Team One
LOS ANGELES, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Legacy Lab, Team One’s award-winning brand consultancy and thought leadership practice, announced today the call for submissions for its annual...
Study Validating MoA of Intranasal Foralumab in Alzheimer’s Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance
06 sept. 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”FDA has cleared the IND for intranasal...
Tiziana Life Sciences Announces Live Bloomberg TV Interview of Renowned Scientist Dr. Howard L. Weiner to Discuss FDA IND Clearance for Intranasal Foralumab in Alzheimer's Disease
17 août 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
NFI Group Inc. announces delivery of the 1,500th electric bus from the BYD–Alexander Dennis partnership
08 août 2023 07h30 HE
|
NFI Group Inc
LARBERT, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader...
Team One Announces New Leadership for Dallas Office
03 août 2023 09h45 HE
|
Team One
Team One Appoints Next Generation Leaders; Putting Creativity and Collaboration on A Pedestal with Organizational Moves. LOS ANGELES, Aug. 03, 2023 (GLOBE NEWSWIRE) -- As an agency that began as a...
Pfizer’s Litfulo Poised to Follow Similar Trajectory as Eli Lilly/Incyte’s Olumiant for the Treatment of Severe Alopecia Areata
11 juil. 2023 09h58 HE
|
Spherix Global Insights
Exton, Pennsylvania, July 11, 2023 (GLOBE NEWSWIRE) -- In June 2022, Eli Lilly and Incyte’s Olumiant became the first and only approved advanced systemic treatment for adults with severe alopecia...